A Phase 2, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination With Bevacizumab and FOLFIRI Versus Bevacizumab and FOLFIRI in Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (CRC)

  • Gill, Sanjeev (Primary Chief Investigator (PCI))
  • Tebbutt, Niall C. (Chief Investigator (CI))
  • Brooks, Christine (Project Manager)
  • Thavaneswaran, Subotheni (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/07/22 → 28/07/23

Keywords

  • Medical oncology
  • Colorectal cancer
  • Clinical trial